The Pediatric Endocrinology and Diabetology Fellowship at IU School of Medicine offers extensive clinical training and outstanding research training for future pediatric endocrinologists. The program has a strong track record in training combined medicine/pediatric endocrinology fellows who have dual board eligibility in four years. Graduates are highly competitive for placement in academic medical centers, private practice, or industry.
Diverse Faculty Interests
Faculty members are accomplished clinicians and are also nationally recognized in their respective areas of clinical and research expertise. The division is known for its excellence in clinical areas of pediatric endocrinology, including disorders of glucose metabolism, bone, puberty, and growth.
Apply
Physicians interested in the Pediatric Endocrinology Fellowship Program can submit an application through ERAS.
Curriculum
Pediatric endocrinology and diabetology fellows spend twelve months in clinical training and 24 months conducting either basic laboratory and/or clinical research.
Research
Fellows in the division have rewarding and fruitful experiences in designing and conducting research projects in their areas of interest.
The Team
Faculty in the division of pediatric endocrinology are dedicated to ensuring the success of fellows, seeking to tailor their experiences to meet their educational and career goals.
Fellow Life
Find out what it's like to be a fellow in the division, about life in Indianapolis, and how the division supports wellness.
Video
Learn more about growing with the Pediatric Endocrinology team
By The Numbers
Fellow Job Placement: 66% Academic Positions, 19% Private Practice
Average Publications: 6.8 publications per fellow. 5.4 abstracts per fellow
Endocrinology Patient Volume: 231 Admissions/year, 319 Consults/year, 12,816 outpatient visits/year
Average Publications: 6.8 publications per fellow. 5.4 abstracts per fellow
Endocrinology Patient Volume: 231 Admissions/year, 319 Consults/year, 12,816 outpatient visits/year
Blogs
Indiana helps drive global progress in Type 1 diabetes screening through TrialNet
More than 250,000 people have been screened for Type 1 diabetes risk worldwide through TrialNet, with over 10,000 screenings conducted locally by IU School of Medicine's TrialNet clinical research center at Riley Children's Health.November 14, 2024
Women in Leadership: Nabhan finds joy in supporting and mentoring medical trainees
Zeina Nabhan, MD, forged her path from a farming village in Lebanon to a faculty leadership position in Graduate Medical Education at IU School of Medicine.September 11, 2024
Indiana University School of Medicine has been selected as an inaugural participant in the Endocrine Society’s Medical School Engagement Program, intended to encourage more medical students to pursue careers in endocrinology. This award will help prepare more specialists in a field currently experiencing a shortage of specialists necessary to manage the increasing number of individuals affected by endocrine-related conditions.
July 16, 2024
IU endocrinologists receive esteemed JDRF awards for contributions to type 1 diabetes research
Two IU School of Medicine faculty members have been recognized for their significant contributions to type 1 diabetes research by the leading global research and advocacy organization for the disease, JDRF. Linda DiMeglio, MPH, MD, was announced as the co-recipient of the 2023 George Eisenbarth Award for Type 1 Diabetes Prevention, and Viral Shah, MD, received the 2023 Mary Tyler Moore and S. Robert Levine, MD, Excellence in Clinical Research Award.April 23, 2024
Clinical trial presents a pill of promise for type 1 diabetes
In March 2023, 10-year-old Emmaline Swigert was diagnosed with type 1 diabetes, an autoimmune disease where the body’s immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. Today, Emmaline is participating in an Indiana University School of Medicine-led clinical trial aimed at testing a pill that could help make life much easier for individuals like her living with the condition.November 13, 2023